EUVIMEDEUVIMED entdecken
Crossref

Targeted Delivery of Celastrol via Chondroitin Sulfate Derived Hybrid Micelles for Alleviating Symptoms in Nonalcoholic Fatty Liver Disease

Yi Pan, Yunxiao Zhang, Hongling Ouyang, Tao Gong iD, Zhirong Zhang iD, Xi Cao, Yao Fu iD

ACS Applied Bio Materials · 20.11.2023 · 6 (11) · 4877-4893

DOI: 10.1021/acsabm.3c00612 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 27.10.2023. Verfasst von Yi Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-So…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Science and Technology Department of Sichuan Province, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonalcoholic fatty liver disease (NAFLD) is caused by an accumulation of excess fat in the liver leading to oxidative stress and liver cell injury, as well as overproduction of inflammatory cytokines. CD44 has been identified as a potential therapeutic target in the development of NAFLD to nonalcoholic steatohepatitis. Here, chondroitin sulfate (CS) is selected to construct a CD44-targeted delivery system for the treatment of NAFLD. Specifically, two CS-derived amphiphilic materials including CS conjugated with either 4-aminophenylboronic acid pinacol ester (CS-PBE) or phenformin (CS-PFM) were synthesized, respectively. The presence of PBE moieties on CS-PBE rendered the vehicle with enhanced loading capacity and scavenging potential against reactive oxygen species, while the presence of guanidine moieties on CS-PFM enhanced the internalization of vehicles in the differentiated hepatocytes. Next, celastrol (CLT) was encapsulated in the hybrid micelle to afford CS-Hybrid/CLT, which demonstrates sufficient stability, enhanced cellular uptake efficiencies in differentiated HepG2 cells, and therapeutic potential to alleviate lipid accumulation in differentiated HepG2 cells. In a high-fat-diet-induced NAFLD rat model, CS-Hybrid/CLT micelles demonstrated the capacity to dramatically decrease hepatic lipid accumulation and free fatty acid levels with greatly improved pathologic liver histology and downregulated hepatic inflammation levels. These results suggest that CS-based amphiphilic micelles may offer a promising strategy to effectively deliver therapeutic cargos to the liver for the treatment of NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseAnimalsRatsMicellesChondroitin SulfatesLipidsPentacyclic Triterpenes

Stichwörter der Autor:innen

CD44-mediated liver targetingcelastrolchondroitin sulfatehybrid micellenonalcoholic fatty liver disease

Substanzen

MicellesChondroitin SulfatesLipidscelastrolPentacyclic Triterpenes

Autor:innen und Institutionen

  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial T…
  • Department of Pharmacy, First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
  • Grade 3 Pharmaceutical Chemistry Laboratory of State Administrate of Traditional Chinese Medicine, Hefei 230022, China.

ORCID-Profile: Tao Gong, Zhirong Zhang, Yao Fu

Förderung

  • Science and Technology Department of Sichuan Province
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Higher Education Discipline Innovation Project

Zitieren

APA

Pan, Y., Zhang, Y., Ouyang, H., Gong, T., Zhang, Z., Cao, X., & Fu, Y. (2023). Targeted Delivery of Celastrol via Chondroitin Sulfate Derived Hybrid Micelles for Alleviating Symptoms in Nonalcoholic Fatty Liver Disease. ACS Applied Bio Materials, 6(11), 4877-4893. https://doi.org/10.1021/acsabm.3c00612

Vancouver

Pan Y, Zhang Y, Ouyang H, Gong T, Zhang Z, Cao X, et al. Targeted Delivery of Celastrol via Chondroitin Sulfate Derived Hybrid Micelles for Alleviating Symptoms in Nonalcoholic Fatty Liver Disease. ACS Applied Bio Materials. 2023;6(11):4877-4893. doi:10.1021/acsabm.3c00612

BibTeX
@article{Pan2023,
  author = {Pan, Yi and Zhang, Yunxiao and Ouyang, Hongling and Gong, Tao and Zhang, Zhirong and Cao, Xi and Fu, Yao},
  title = {Targeted Delivery of Celastrol via Chondroitin Sulfate Derived Hybrid Micelles for Alleviating Symptoms in Nonalcoholic Fatty Liver Disease},
  journal = {ACS Applied Bio Materials},
  year = {2023},
  volume = {6},
  number = {11},
  pages = {4877--4893},
  doi = {10.1021/acsabm.3c00612}
}
Kostenlos starten →